Atopic Dermatitis Anti-IgE Paediatric Trial (ADAPT): the role of anti-IgE in severe paediatric eczema: study protocol for a randomised controlled trial

Overview of attention for article published in Trials, March 2017

Altmetric Badge

Mentioned by

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 12,056 followers.

RT @ISRCTN: Study of anti-IgE (omalizumab) for severe paediatric #eczema: protocol via #ISRCTN and #Trialsjournal https://t.co/9aOFVkNIxb…

RT @ISRCTN: Study of anti-IgE (omalizumab) for severe paediatric #eczema: protocol via #ISRCTN and #Trialsjournal https://t.co/9aOFVkNIxb…

RT @ISRCTN: Study of anti-IgE (omalizumab) for severe paediatric #eczema: protocol via #ISRCTN and #Trialsjournal https://t.co/9aOFVkNIxb…

Study of anti-IgE (omalizumab) for severe paediatric #eczema: protocol via #ISRCTN and #Trialsjournal https://t.co/9aOFVkNIxb #NIHR

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.